Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Pneumocystosis
| Pneumocystosis | |
|---|---|
| Other names | Pneumocystis jiroveci pneumonia,[1] Pneumocystis pneumonia,[2] PCP, Pneumocystis carinii pneumonia[3] |
 | |
| Pneumocystis jirovecii cysts | |
| Specialty | Infectious diseases[1] |
| Symptoms | |
| Complications |
|
| Types |
|
| Causes | Pneumocystis jirovecii[1] |
| Risk factors | Poor immunity, HIV/AIDS[4] |
| Diagnostic method | Medical imaging, bronchoalveolar lavage, immunofluorescence assay, biopsy[2] |
| Prevention | Trimethoprim/sulfamethoxazole (co-trimoxazole) in high risk groups[7] |
| Medication | Trimethoprim/sulfamethoxazole (co-trimoxazole)[4] |
| Frequency | Uncommon,[4] 97% in lungs[7] |
Pneumocystosis is a fungal infection that most often presents as Pneumocystis pneumonia in people with HIV/AIDS or poor immunity.[1][7] It usually causes cough, difficulty breathing and fever, and can lead to respiratory failure.[4] Involvement outside the lungs is rare but, can occur as a disseminated type affecting lymph nodes, spleen, liver, bone marrow, eyes, kidneys, thyroid, gastrointestinal tract or other organs.[5][7] If occurring in the skin, it usually presents as nodular growths in the ear canals or underarms.[3]
It is caused by Pneumocystis jirovecii, a fungus which is usually breathed in and found in the lungs of healthy people without causing disease, until the person's immune system becomes weakened.[7]
Diagnosis is by identifying the organism from a sample of fluid from affected lungs or a biopsy.[3][4] Prevention in high risk people, and treatment in those affected is usually with trimethoprim/sulfamethoxazole (co-trimoxazole).[4][8]
The prevalence is unknown.[7] Less than 3% of cases do not involve the lungs.[7] The first cases of pneumocystosis affecting lungs were described in premature infants in Europe following the Second World War.[9]
- ^ a b c d "ICD-11 - ICD-11 for Mortality and Morbidity Statistics". icd.who.int. Retrieved 30 June 2021.
- ^ a b Russell-Goldman, Eleanor; Milner, Dan A.; Solomon, Isaac (2020). "Pneumocystosis". In Milner, Danny A. (ed.). Diagnostic Pathology: Infectious Diseases. Elsevier. pp. 310–313. ISBN 978-0-323-61138-1.
- ^ a b c Cite error: The named reference
Dermnetzwas invoked but never defined (see the help page). - ^ a b c d e f g h "Orphanet: Pneumocystosis". www.orpha.net. Archived from the original on 24 July 2021. Retrieved 24 July 2021.
- ^ a b c Ioachim, Harry L.; Medeiros, L. Jeffrey (2009). "28. Pneumocystosis lymphadenitis". Ioachim's Lymph Node Pathology (4th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 156–157. ISBN 978-0-7817-7596-0.
- ^ a b c Calonje, J. Eduardo; Grayson, Wayne (2020). "18. Infectious diseases of the skin". In Calonje, J. Eduardo; Brenn, Thomas; Lazar, Alexander J.; Billings, Steven D. (eds.). McKee's Pathology of the Skin, 2 Volume Set (5th ed.). Elsevier. p. 964. ISBN 978-0-7020-6983-3.
- ^ a b c d e f g h i Cite error: The named reference
CDC/DPDxwas invoked but never defined (see the help page). - ^ Cite error: The named reference
CDCFungalwas invoked but never defined (see the help page). - ^ Carmona, Eva M.; Limper, Andrew H. (February 2011). "Update on the diagnosis and treatment of Pneumocystis pneumonia". Therapeutic Advances in Respiratory Disease. 5 (1): 41–59. doi:10.1177/1753465810380102. ISSN 1753-4666. PMC 6886706. PMID 20736243.
Previous Page Next Page
